Introduction
Isolated deficiencies of peroxisomal -oxidation enzymesacyl-coenzyme A (CoA) oxidase (Poll-The et al. 1988 , Suzuki et al. 1994a , 3-ketoacyl-CoA thiolase (Schram et al. 1987) , enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase bifunctional protein (l-BP) (Watkins et al. 1989) , and d-3-hydroxyacyl-CoA dehydratase/d-3-hydroxyacyl-CoA dehydrogenase bifunctional protein (d-BP) , are characterized by the manifestation of severe psychomotor retardation and the accumulation of very-long-chain fatty acids (VLCFAs). Only VLCFAs accumulate in patients with acyl-CoA oxidase deficiency (Poll-The et al. 1988) , whereas both VLCFAs and bile acid intermediates accumulate in patients with l-BP and d-BP deficiency (Watkins et al. 1989 .
d-BP converts enoyl-CoAs to 3-ketoacyl-CoAs via d-3-hydroxyacyl-CoAs in peroxisomes (Jiang et al. 1996a (Jiang et al. , 1996b . Peroxisomal -oxidation in human skin fibroblasts proceeds mainly by d-BP, but not by l-BP, as the content and activity of l-BP are very low in fibroblasts compared with that of d-BP (Jiang et al. 1997a ). Bile acid precursors and 2-methyl-branched fatty acids are also catalyzed by d-BP (Jiang et al. 1997a) .
Recently, we reported the first two patients with d-BP deficiency ) who were diagnosed as having l-BP deficiency by means of a complementation study using an established cell line with l-BP deficiency (Suzuki et al. 1994a (Suzuki et al. , 1996 . Enzyme activity and d-BP immunoreactive material were markedly reduced compared with the controls, and deletions in the cDNA were identified . We proposed that patients previously diagnosed as having l-BP deficiency should be reexamined for possible d-BP deficiency. Here we present the first experience of the prenatal diagnosis of d-BP deficiency. Peroxisomal -oxidation activity in cultured amniocytes from a fetus at 16 weeks' gestational age was markedly decreased compared with the controls and d-BP was absent on immunoblot analysis and immunofluorescence staining of cultured amniocytes. The same 237-bp deletion as that in a sibling (the proband) was detected in the cDNA. Biochemical and immunohistochemical studies confirmed that the fetus was affected.
Methods

Patients and fetuses
The proband was the second female child of nonconsanguineous parents of Japanese origin. Soon after birth, she manifested profound hypotonia, psychomotor delay, intractable convulsions, craniofacial dysmorphism (large fontanelle, frontal bossing, low nasal bridge, and upward-slanting of palpebral fissures), funnel chest, talipes equinovarus, calcific stippling of the patella, and hepatomegaly. She died of pneumonia at 12 months of age (Nakada et al. 1993 ). Accumulation of VLCFAs in plasma, and low lignoceric acid oxidation activity and d-BP activity in fibroblasts, as well as deficient immunoreactive d-BP material, were revealed. Molecular analyses revealed the presence of a 237-bp deletion in the cDNA of d-BP .
The third and fourth children were prenatally diagnosed as healthy by determination of lignoceric acid oxidation activity, and the diagnosis was confirmed by VLCFA analysis after birth (Table 1 ). In this study we examined cultured amniocytes and autopsied fetal tissue specimens from the fifth child. Control specimens (fibroblasts, amniocytes, and autopsied tissues) were obtained with permission from patients with other disorders.
Methods
Amniocytes obtained at 16 weeks' gestational age were cultured in MEM (Nissui, Tokyo, Japan). For immunofluorescence staining, about 1 ϫ 10 4 cells were seeded on a sterile cover slip in a 3.5-cm dish. For lignoceric acid oxidation, two dishes, each containing 1 ϫ 10 5 cells, were used (Suzuki et al. 1994b ). Peroxisomal -oxidation activity was assessed by measuring the degradation products of [1-14 C] lignoceric acid (CEA; Gif-Sur-Yvette, France) added to the medium, according to the method of Suzuki et al. (1991) with slight modifications. Amniocytes were preincubated with fetal calf serum-free MEM. The fatty acid oxidation reaction was initiated by adding 4 nmol of [1-14 C] lignoceric acid. After the preparation was incubated at 37°C for 1 h, the medium was chilled on ice, and the unreacted fatty acid was removed. Radioactive degradation products were counted in a spectrophotometer. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and western blotting were carried out as described (Laemmli 1970 , Towbin et al. 1979 . Color development was done with alkaline phosphatase-conjugated goat anti-rabbit IgG antibody and an NBT/BCIP substrate kit (Promega, Madison, WI, USA). Immunofluorescence staining of peroxisomes was performed as described (Suzuki et al. 1990 ), using rabbit anti-human catalase or anti-human d-BP antibodies. Extraction of mRNA from amniocytes, reverse transcriptase (RT)-polymerase chain reaction (PCR), and agarose gel electrophoresis were done as described , Jiang et al. 1997b , with the primer set 5Ј-TGTCGTTGCAGGCCTTATTC-3Ј and 5Ј-TAATAGTGTAGTGTGCCCTTC-3Ј. Autopsied tissues were either kept at Ϫ80°C for biochemical studies or fixed with 10% formalin for pathology studies. Immunohistochemistry of formalin-fixed paraffin-embedded tissues was performed by the peroxidase-antiperoxidase method, using anti-human d-BP antibody (Imamura et al. 1995) .
Results
Biochemical and molecular analyses of amniocytes
Cultured amniocytes from the third and fourth children showed normal lignoceric acid oxidation activity, whereas the present fetus (the fifth child) showed decreased activity (Table 1) . On immunoblot analysis, the 77-kDa band of d-BP was absent in amniocytes from the present fetus as was the case with the proband, while immunoreactive material was clearly detected in the control fibroblasts (Fig. 1) . Several faint smaller bands detected in the proband, the fetus, Fig. 2 . Indirect immunofluorescence staining. A Catalase (control fibroblasts); B catalase (present fetus, amniocytes); C d-BP (control fibroblasts); D d-BP (present fetus, amniocytes). Bar ϭ 10 µm and the controls were considered to be nonspecific. Immunofluorescence staining with anti-human catalase antibody revealed that peroxisomes were larger and fewer in number in the present fetus than in the controls (Fig. 2B) , as was the case with the proband , whereas practically no peroxisomes were detected in the present fetus when we used anti-human d-BP antibody (Fig. 2D) . RT-PCR using specific primers for d-bifunctional protein revealed a 237-bp deletion in the cDNA of the present fetus (Fig. 3) , which had also been identified in the proband ). These results indicated that the present fetus was affected.
Immunohistochemical and biochemical analyses of fetal tissues
The parents were informed of the findings and they decided to terminate the pregnancy. They gave permission for an autopsy of the fetus. Fatty acid analysis of the cord blood revealed the accumulation of VLCFAs (Table 1) . The fetus showed the characteristic facial appearance of d-BP deficiency, such as high forehead and low nasal bridge. Neuropathological examination revealed a cortical columnar cell arrangement with subcortical cells remaining in the cerebral hemisphere, and an immature cortex in the cerebellar hemisphere. However, there was no apparent neuronal migration disorder in the brain. Basal ganglia were normal. Liver and kidney tissues were normal in appear- microgyria, and simplified convolutions of the inferior olive, manifestations that are similar to those observed in Zellweger syndrome, a generalized peroxisome biogenesis disorder. Pathology examinations of the present fetus did not reveal the characteristic findings of neuronal migration disorders at 20 weeks of gestation. However, the presence of facial dysmorphism suggests that the pathological changes due to this enzyme deficiency had already progressed in mid-trimester, as is the case with Zellweger syndrome. In our immunohistochemical studies of the control fetus at 20 weeks of gestation, d-BP was strongly expressed in liver, kidney, and neurons (data not shown), suggesting that d-BP could play important roles in the development of fetal tissues, especially in the brain.
ance (data not shown). Immunoreactive d-BP material was absent in the liver, kidney, and brain tissues on immunoblot analysis. In the control fetus, d-BP was clearly identified. The absence of d-BP in the present fetus was also clarified by immunohistochemical staining of the liver (Fig. 4A) , whereas d-BP was strongly expressed in the control fetal liver at 20 weeks of gestation (Fig. 4B ).
Discussion
We have reported the presence of the novel peroxisomaloxidation enzyme, d-BP (Jiang et al. 1996a (Jiang et al. , 1996b (Jiang et al. , 1997a , and its congenital deficiency . l-BP deficiency was formerly considered to be the most frequent disorder among peroxisomal -oxidation enzyme defects (Watkins et al. 1995) . We proposed that patients previously diagnosed with l-BP deficiency should be re-examined for possible d-BP deficiency, and a recent study (van Grunsven et al. 1998) confirmed that the original case of possible l-BP deficiency reported by Watkins et al. (1989) was indeed d-BP deficiency. Based on these finding it seems that d-BP deficiency is the most frequent disorder among peroxisomal -oxidation defects, and it is necessary to develop precise methods for its prenatal diagnosis.
Here we reported our experience of the first case of the prenatal diagnosis of d-BP deficiency and confirmed that several methods, including lignoceric acid oxidation assay, immunoblot, immunofluorescence staining, and RT-PCR were useful for the prenatal diagnosis of d-BP deficiency. These examinations, together, should provide us with precise results on a prenatal diagnosis of d-BP deficiency. Compared with l-BP, d-BP is much more abundant in amniocytes, and it was easy to detect d-BP immunoreactive material in amniocytes by immunoblotting or immunofluorescence staining. Although several smaller bands other than d-BP were detected on immunoblot analyses, these bands were considered to be nonspecific, since practically no immunoreactivity was observed in the fetus on immunofluorescence staining and immunohistochemistry (Figs. 2, 4) .
In the report of Kaufmann et al. (1996) , an infant with bifunctional enzyme deficiency manifested neuronal migration disorder, showing heterotopic neurons, poly- 
